Navigation Links
DIA/FDA/PhRMA to Host Progression-Free Survival Oncology Workshop
Date:8/26/2009

The Drug Information Association (DIA), in cooperation with FDA and PhRMA, will host Progression-Free Survival Oncology Workshop from October 7-9, 2009 in Bethesda, MD.

Horsham, PA (Vocus) August 26, 2009 -- The Drug Information Association (DIA), in cooperation with FDA and PhRMA, will host Progression-Free Survival Oncology Workshop from October 7-9, 2009 in Bethesda, MD.

Progression-Free Survival (PFS) endpoints are increasingly used for evaluation and approval of oncology drugs. Representatives from FDA, the National Cancer Institute (NCI), and PhRMA will present their perspectives on clinical, radiological, and statistical evaluation of progression-free survival. Sessions will include:

 
  • Clinical Assessment of Progression-Free Survival (PFS)
  • Radiological Evaluation of Progression-Free Survival (PFS)
  • Criteria for Determination of Progression
  • Statistical Evaluation of Progression-Free Survival- Role and Design of Independent Review
  • Statistical Evaluation of Progression-Free Survival--Handling Missing/Censored Observations
  • Statistical Evaluation of Progression-Free Survival--Analysis of Progression-Free Survival
  • Regulatory Considerations
Richard Pazdur, MD, Director, Office of Oncology Drug Products, CDER, FDA, will deliver the keynote address. In addition to his experience as a regulatory expert at FDA, Dr. Pazdur has distinguished himself in clinical and academic oncology. Click here for complete bio.

In addition, two tutorials will be held on October 7:

 
  • Time to Event Analysis for Non-Statisticians
  • Statistical Methods for Interval Censored Data Analyses
Click here to register for the Progression-Free Survival Oncology Workshop.

About the Drug Information Association (DIA):
DIA serves more than 30,000 professionals involved in the biopharmaceutical industry and regulatory affairs worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit www.diahome.org or call 215-442-6100.

Contact:
Joe Krasowski
DIA
+1-215-293-5812

###

Read the full story at http://www.prweb.com/releases/2009/08/prweb2796274.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. DIA/FDA/PhRMA Drug Safety Conference: Planning the Lifecycle of Safety Evaluation
2. Advanced lung cancer patients see improved, progression-free survival
3. Nexavar in Combination with Chemotherapy Shown to Extend Progression-Free Survival in Patients with Advanced Breast Cancer
4. Journal of Clinical Oncology Publishes TREANDA Study Demonstrating Significant Improvement in Overall Response and Progression-Free Survival in Chronic Lymphocytic Leukemia
5. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
6. Survival differences by race most apparent in advanced stages of breast cancer
7. Prophylactic cranial irradiation in small cell lung cancer significantly increases survival
8. Human C-reactive protein regulates myeloma tumor cell growth and survival
9. Mediterranean Diet May Boost Alzheimers Survival
10. Hospitals Improve Survival Rates While Treating Sicker Patients Thomson Healthcare Study Shows
11. The Fight for His Life: Author, Family Battle Disease and Challenge Politics in the Face of Survival
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... Santa Rosa, California (PRWEB) , ... May 24, ... ... management (PHM) technology, debuted a new corporate identity and website at its “Transforming ... brand, website, and other marketing enhancements reflect i2i’s ongoing success to set the ...
(Date:5/24/2016)... ... May 24, 2016 , ... ... Center at Sentara Northern Virginia Medical Center located in Woodbridge, VA. The ... surgical services into a single site. , The new 2 story building houses ...
(Date:5/24/2016)... ... (PRWEB) May 24, 2016 -- Grow Healthy ... Advisory Board. Joining the Grow Healthy Advisory Board team are ... embody the mission of our organization and bring talent, expertise and ... as we continue to expand our footprint as the leader in ...
(Date:5/24/2016)... PA (PRWEB) , ... May 24, 2016 , ... A ... will rely heavily on their access to trusted resources, both in face-to-face interactions and ... Young Men of Color,” researchers concluded that the creative use of mobile digital devices ...
(Date:5/24/2016)... ... May 24, 2016 , ... ... increased by 9.3 million people, or 10% over last year, according to data ... covered under group policies was comparatively stable, with a slight decrease in risk-based ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... , May 23, 2016 ... Size, Share, Development, Growth and Demand Forecast to ... and Other), by Application (Drug Discovery and Development, ... Users (Pharmaceuticals, Life Science and Biotechnology, Academic and ... Market Research, the global mass spectrometry market ...
(Date:5/23/2016)... , May 23, 2016 Non-invasive ... detection of multiple diseases; ,Technology to be presented at ... Yissum Research Development Company of the Hebrew University ... a research agreement with Aurum Ventures MKI, the technology investment ... of a new diagnostic approach for early detection of ...
(Date:5/23/2016)... -- The global  reprocessed medical devices market ... according to a new study by Grand View Research, ... the lack of centralized support for waste disposal in ... for reprocessed medical devices market. Additionally, the long-term cost-efficiency ... the original device is the high impact rendering driver ...
Breaking Medicine Technology: